コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 patients who received alemtuzumab or rabbit antilymphocyte globulin.
2 on; CsA pigs (n= 14) received CsA (5 mg/kg), antilymphocyte globulin (10 mg/kg for 10 days), predniso
3 ding to the use of induction therapy: rabbit antilymphocyte globulin (5-year rate 6.8%, 4/59), alemtu
6 uction, old antibody era, 1987 to 1993, when antilymphocyte globulin and muromonab-CD3 were the major
7 antithymocyte globulin (rATG; 1999) replaced antilymphocyte globulin and muromonab-CD3, with maintena
8 onsisted of induction therapy with Minnesota antilymphocyte globulin/antithymocyte globulin/OKT3 in m
10 after treatment with corticosteroids equine antilymphocyte globulin (ATGAM), or the mouse anti-human
11 es in patients who received either Minnesota antilymphocyte globulin for 5 days or more or OKT3 for 7
12 ey transplants, graft failure and the use of antilymphocyte globulin for rejection are associated wit
14 mycophenolate mofetil, azathioprine, OKT-3, antilymphocyte globulin), only the use of antilymphocyte
15 us or cytomegalovirus status, induction with antilymphocyte globulin or antithymocyte globulin (ATG),
16 ents received 5-7 days of induction therapy (antilymphocyte globulin or antithymocyte globulin), wher
17 course of antithymocyte globulin, Minnesota antilymphocyte globulin, or OKT3 before developing PTLD.
18 d irradiation (TLI), rabbit antithymocyte or antilymphocyte globulin (RATG or RALG), and a single don
19 3, antilymphocyte globulin), only the use of antilymphocyte globulin when used to treat rejection was
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。